SCHEMBL9890273

SCHEMBL9890273

c1ccc(-c2ccc3c(c2)c2cc(-c4cccc5c4oc4cc6c(cc45)oc4c(-n5c7ccccc7c7ccccc75)cccc46)ccc2n3-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PRKDC P78527 7/20 0.36
GGPS1 O95749 1/20 0.34
TSPO P30536 2/20 0.32
ALDH1A1 P00352 3/20 0.31
TSHR P16473 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
BRCA1 P38398 1/20 0.31
KMT2A Q03164 1/20 0.31
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
DNM1 Q05193 1/20 0.31
PTGES2 Q9H7Z7 1/20 0.31
PIK3CD O00329 2/20 0.30
PIK3CA P42336 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9890264 0.97 KDM4E (0.41) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL1635444 0.92 ALOX5 (0.44) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL1636922 0.91 ALOX5 (0.43) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL1635829 0.91 KDM4E (0.46) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL12925677 0.91 ALOX5 (0.40) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL20654715 0.90 ALOX5 (0.42) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL16482570 0.90 L3MBTL1 (0.43) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL10331651 0.90 KDM4E (0.43) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL15780918 0.90 KDM4E (0.43) ALOX5KDM4EATML3MBTL1PRKDC
SCHEMBL5028253 0.90 KDM4E (0.45) ALOX5KDM4EATML3MBTL1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 ALOX5 2756/4885KDM4E 990/4885ATM 3103/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 ALOX5 2756/4885KDM4E 990/4885ATM 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.